The acquisition will add 200,000 square feet, expanding the company’s total footprint to 500,000 square feet, a spokesperson for the company told us. It expects the new facilities to be staffed and operational by early summer of 2020 after quality audits.
It will be located near its headquarters in West Caldwell, NJ.
In a press release, the company said that the new leased facility will make Vitaquest “one of the largest companies of its kind in the United States,” increasing the company’s manufacturing, warehousing, product development and laboratory space by over 50%.
The manufacturing space will be divided to support multiple operations, including pharmacy, blending, encapsulation, and compression departments.
Vitaquest’s growth
The company makes over 4,000 custom products each year. Among this, it produces more than 2 billion doses of tablets annually, as well as different forms of capsules and powders. It also manufactures probiotic supplements.
For packaging, Vitaquest offers bottles, jars, unit dose pouches, stick packs, vials, blister cards, and more.
“Over the last several years, Vitaquest has grown at an exceptional pace as we have continued to build our business and provide our customers with the absolute best service available in the nutraceutical industry,” said Patrick Brueggman, CEO of Vitaquest.
“We owe this success to our dedicated and hard-working employees who have shown time after time why Vitaquest is the most innovative and outstanding company in our industry. This is the most significant investment in the history of our company and testifies to the bright future that Vitaquest envisions for both our employees and our customers,” he added.
It's an exciting time for the company, said Rick Handel, the company’s SVP of commercial operations.
“We have just received FSSC 22000 Food Safety Certification, which is a testament to our ability to manage quality at an industry-leading level,” he said. “We look forward to offering our customers faster turnaround with state-of-the-art innovation and flawless execution on their products – so we continue to deliver what’s next.”
